» Articles » PMID: 22745906

Inflammation and Joint Tissue Interactions in OA: Implications for Potential Therapeutic Approaches

Overview
Journal Arthritis
Specialty Rheumatology
Date 2012 Jun 30
PMID 22745906
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

It is increasingly recognized that the pathogenesis of cartilage degradation in osteoarthritis (OA) is multifactorial and involves the interactions between cartilage and its surrounding tissues. These interactions regulate proinflammatory cytokine-mediated cartilage destruction, contributing to OA progression as well as cartilage repair. This review explores the pathogenesis of OA in the context of the multiple tissue types in the joint and discusses the implications of such complex tissue interaction in the development of anti-inflammatory therapeutics for the treatment of OA.

Citing Articles

Utilising Discriminant Function Analysis (DFA) for Classifying Osteoarthritis (OA) Patients and Volunteers Based on Biomarker Concentration.

Coleman L, Byrne J, Edwards S, OHara R Diagnostics (Basel). 2024; 14(15).

PMID: 39125536 PMC: 11311323. DOI: 10.3390/diagnostics14151660.


The CREB1 inhibitor 666-15 maintains cartilage homeostasis and mitigates osteoarthritis progression.

Wang Y, Wu Z, Yan G, Li S, Zhang Y, Li G Bone Joint Res. 2024; 13(1):4-18.

PMID: 38163445 PMC: 10758301. DOI: 10.1302/2046-3758.131.BJR-2023-0016.R2.


The influence of vitamin D supplementation on the expression of mediators of inflammation in knee osteoarthritis.

Divjak A, Jovanovic I, Matic A, Lucic A, Gajovic N, Jurisevic M Immunol Res. 2022; 71(3):442-450.

PMID: 36571658 DOI: 10.1007/s12026-022-09354-0.


Osteoarthritis Pain in Old Mice Aggravates Neuroinflammation and Frailty: The Positive Effect of Morphine Treatment.

Amodeo G, Franchi S, Galimberti G, Comi L, DAgnelli S, Baciarello M Biomedicines. 2022; 10(11).

PMID: 36359375 PMC: 9687902. DOI: 10.3390/biomedicines10112847.


Cutting-Edge Technologies for Inflamed Joints on Chip: How Close Are We?.

Kahraman E, Ribeiro R, Lamghari M, Neto E Front Immunol. 2022; 13:802440.

PMID: 35359987 PMC: 8960235. DOI: 10.3389/fimmu.2022.802440.


References
1.
Lawyer T, Wingerter S, Tucci M, Benghuzzi H . Cellular effects of catabolic inflammatory cytokines on chondrocytes - biomed 2011. Biomed Sci Instrum. 2011; 47:252-7. View

2.
Lories R, Luyten F . The bone-cartilage unit in osteoarthritis. Nat Rev Rheumatol. 2010; 7(1):43-9. DOI: 10.1038/nrrheum.2010.197. View

3.
Beekhuizen M, Bastiaansen-Jenniskens Y, Koevoet W, Saris D, Dhert W, Creemers L . Osteoarthritic synovial tissue inhibition of proteoglycan production in human osteoarthritic knee cartilage: establishment and characterization of a long-term cartilage-synovium coculture. Arthritis Rheum. 2011; 63(7):1918-27. DOI: 10.1002/art.30364. View

4.
Malemud C . Anticytokine therapy for osteoarthritis: evidence to date. Drugs Aging. 2010; 27(2):95-115. DOI: 10.2165/11319950-000000000-00000. View

5.
Flandry F, Hommel G . Normal anatomy and biomechanics of the knee. Sports Med Arthrosc Rev. 2011; 19(2):82-92. DOI: 10.1097/JSA.0b013e318210c0aa. View